Concepedia

Fumikazu Wanibuchi

FW

Statistics

Publications

13

Citations

519

H-Index

12

Active since

1990

Affiliations

Astellas Pharma (Japan)(Current)

Drug Discovery Laboratory (Norway)

Central Research Laboratories (United Kingdom)

Fumikazu Wanibuchi is an author at Astellas Pharma (Japan) specializing in pharmacology, medicine, and drug discovery.

Top concepts

Publications per year

1990–2008

13

Publications

13

Allodynia and Hyperalgesia in Adjuvant-Induced Arthritic Rats: Time Course of Progression and Efficacy of Analgesics

Yukinori Nagakura, Masamichí Okada, Atsuyuki Kohara et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 175 citations

Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats

Fumikazu Wanibuchi, Shinji Usuda · Psychopharmacology · 1990 · 54 citations

, , +13

Pharmacological profile of YM348, a novel, potent and orally active 5-HT2C receptor agonist

Yasuharu Kimura, Ken-ichi Hatanaka, Yuki Naitou et al. · European Journal of Pharmacology · 2003 · 52 citations · Full text

, , +5

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

Fumikazu Wanibuchi, Takako Nishida, Hiroshi Yamashita et al. · European Journal of Pharmacology · 1994 · 40 citations

, , +7

Pharmacological studies on novel muscarinic agonists, 1-oxa-8-azaspiro[4.5]decane derivatives, YM796 and YM954

Fumikazu Wanibuchi, Takako Konishi, Masatomi Harada et al. · European Journal of Pharmacology · 1990 · 37 citations

, , +9

1–5 of 13